Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Henry Ginsberg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Liver

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
34
Brown, Virgil
29
Ramakrishnan, Rajasekhar
14
Holleran, Steve
12
Wu, X
10
Berglund, Lars
7
Goldberg, Ira
7
Fisher, Edward
7
Hernandez-Ono, Antonio
6
Ngai, Colleen
6
Huang, Li-Shin
6
Zhang, Yuan-Li
6
Zhou, Ming
5
Jiang, Hong
5
Fisher, Edward
5
Blaner, William

Sign-in to see all Coauthors

Publications

TOP 3
Ginsberg Henry N; Woods Stephen C
The endocannabinoid system: potential for reducing cardiometabolic risk.
Ginsberg Henry N; Maccallum Paul R
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
Reyes-Soffer Gissette; Holleran Steve; Karmally Wahida; Ngai Colleen I; Chen Niem-Tzu; Torres Margarita; Ramakrishnan Rajasekhar; Blaner William S; Berglund Lars; Ginsberg Henry N; Tuck Catherine
Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Henry Ginsberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ginsberg Henry N; Woods Stephen C
The endocannabinoid system: potential for reducing cardiometabolic risk.
Obesity (Silver Spring, Md.) 2009;17(10):1821-9.
2009: Ginsberg Henry N; Maccallum Paul R
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(9):520-7.
2009: Reyes-Soffer Gissette; Holleran Steve; Karmally Wahida; Ngai Colleen I; Chen Niem-Tzu; Torres Margarita; Ramakrishnan Rajasekhar; Blaner William S; Berglund Lars; Ginsberg Henry N; Tuck Catherine
Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus.
Journal of lipid research 2009;50(9):1901-9.
2009: Ginsberg Henry N; Fisher Edward A
The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.
Journal of lipid research 2009;50 Suppl():S162-6.
2009: Ginsberg Henry N; MacCallum Paul R
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
Journal of the cardiometabolic syndrome 2009;4(2):113-9.
2008: Fruchart Jean-Charles; Sacks Frank; Hermans Michel P; Assmann Gerd; Brown W Virgil; Ceska Richard; Chapman M John; Dodson Paul M; Fioretto Paola; Ginsberg Henry N; Kadowaki Takashi; Lablanche Jean-Marc; Marx Nikolaus; Plutzky Jorge; Reiner Zeljko; Rosenson Robert S; Staels Bart; Stock Jane K; Sy Rody; Wanner Christoph; Zambon Alberto; Zimmet Paul
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
The American journal of cardiology 2008;102(10 Suppl):1K-34K.
2008: Fruchart Jean-Charles; Sacks Frank M; Hermans Michel P; Assmann Gerd; Brown W Virgil; Ceska Richard; Chapman M John; Dodson Paul M; Fioretto Paola; Ginsberg Henry N; Kadowaki Takashi; Lablanche Jean-Marc; Marx Nikolaus; Plutzky Jorge; Reiner Zeljko; Rosenson Robert S; Staels Bart; Stock Jane K; Sy Rody; Wanner Christoph; Zambon Alberto; Zimmet Paul;
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(4):319-35.
2008: Barter Philip; Ginsberg Henry N
Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.
The American journal of cardiology 2008;102(8):1040-5.
2008: Ginsberg Henry N; Ramakrishnan Rajasekhar
Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(10):1685-6.
2008: Miller Michael; Ginsberg Henry N; Schaefer Ernst J
Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
The American journal of cardiology 2008;101(7):1003-8.
2008: Reyes Gissette; Yasunaga Koichi; Rothenstein Eileen; Karmally Wahida; Ramakrishnan Rajasekhar; Holleran Stephen; Ginsberg Henry N
Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance.
Journal of lipid research 2008;49(3):670-8.
2008: Biddinger Sudha B; Hernandez-Ono Antonio; Rask-Madsen Christian; Haas Joel T; Alemán José O; Suzuki Ryo; Scapa Erez F; Agarwal Chhavi; Carey Martin C; Stephanopoulos Gregory; Cohen David E; King George L; Ginsberg Henry N; Kahn C Ronald
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
Cell metabolism 2008;7(2):125-34.
2008: Ota Tsuguhito; Gayet Constance; Ginsberg Henry N
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.
The Journal of clinical investigation 2008;118(1):316-32.
2007: Berglund Lars; Lefevre Michael; Ginsberg Henry N; Kris-Etherton Penny M; Elmer Patricia J; Stewart Paul W; Ershow Abby; Pearson Thomas A; Dennis Barbara H; Roheim Paul S; Ramakrishnan Rajasekhar; Reed Roberta; Stewart Kent; Phillips Katherine M;
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states.
The American journal of clinical nutrition 2007;86(6):1611-20.
2007: Saito Shinichiro; Hernandez-Ono Antonio; Ginsberg Henry N
Dietary 1,3-diacylglycerol protects against diet-induced obesity and insulin resistance.
Metabolism: clinical and experimental 2007;56(11):1566-75.
2007: Saland Jeffrey M; Ginsberg Henry N
Lipoprotein metabolism in chronic renal insufficiency.
Pediatric nephrology (Berlin, Germany) 2007;22(8):1095-112.
2007: Davidson Michael H; Stein Evan A; Bays Harold E; Maki Kevin C; Doyle Ralph T; Shalwitz Robert A; Ballantyne Christie M; Ginsberg Henry N;
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Clinical therapeutics 2007;29(7):1354-67.
2007: Ginsberg Henry N; Bonds Denise E; Lovato Laura C; Crouse John R; Elam Marshall B; Linz Peter E; O'connor Patrick J; Leiter Lawrence A; Weiss Daniel; Lipkin Edward; Fleg Jerome L;
Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):56i-67i.
2007: Goff David C; Gerstein Hertzel C; Ginsberg Henry N; Cushman William C; Margolis Karen L; Byington Robert P; Buse John B; Genuth Saul; Probstfield Jeffrey L; Simons-Morton Denise G;
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):4i-20i.
2007: Buse John B; Bigger J Thomas; Byington Robert P; Cooper Lawton S; Cushman William C; Friedewald William T; Genuth Saul; Gerstein Hertzel C; Ginsberg Henry N; Goff David C; Grimm Richard H; Margolis Karen L; Probstfield Jeffrey L; Simons-Morton Denise G; Sullivan Mark D
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
The American journal of cardiology 2007;99(12A):21i-33i.
2007: Yasunaga Koichi; Saito Shinichiro; Zhang Yuan-Li; Hernandez-Ono Antonio; Ginsberg Henry N
Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice.
Journal of lipid research 2007;48(5):1108-21.
2007: Buse John B; Ginsberg Henry N; Bakris George L; Clark Nathaniel G; Costa Fernando; Eckel Robert; Fonseca Vivian; Gerstein Hertzel C; Grundy Scott; Nesto Richard W; Pignone Michael P; Plutzky Jorge; Porte Daniel; Redberg Rita; Stitzel Kimberly F; Stone Neil J;
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Circulation 2007;115(1):114-26.
2007: Buse John B; Ginsberg Henry N; Bakris George L; Clark Nathaniel G; Costa Fernando; Eckel Robert; Fonseca Vivian; Gerstein Hertzel C; Grundy Scott; Nesto Richard W; Pignone Michael P; Plutzky Jorge; Porte Daniel; Redberg Rita; Stitzel Kimberly F; Stone Neil J;
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Diabetes care 2007;30(1):162-72.
2006: Zhang Yuan-Li; Hernandez-Ono Antonio; Siri Patty; Weisberg Stuart; Conlon Donna; Graham Mark J; Crooke Rosanne M; Huang Li-Shin; Ginsberg Henry N
Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
The Journal of biological chemistry 2006;281(49):37603-15.
2006: Chahil Tina J; Ginsberg Henry N
Diabetic dyslipidemia.
Endocrinology and metabolism clinics of North America 2006;35(3):491-510, vii-viii.
2006: Ginsberg Henry N
Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
Cell metabolism 2006;4(3):179-81.
2006: Yamaguchi Junji; Conlon Donna M; Liang John J; Fisher Edward A; Ginsberg Henry N
Translocation efficiency of apolipoprotein B is determined by the presence of beta-sheet domains, not pause transfer sequences.
The Journal of biological chemistry 2006;281(37):27063-71.
2006: Ginsberg Henry N
Niacin in the metabolic syndrome: more risk than benefit?
Nature clinical practice. Endocrinology & metabolism 2006;2(6):300-1.
2006: Crouse John R; Elam Marshall B; Robinson Jennifer G; Ambrosius Walter T; Ginsberg Henry N
Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
The American journal of cardiology 2006;97(11):1667-9.
2006: Goldberg Ira J; Ginsberg Henry N
Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease.
Gastroenterology 2006;130(4):1343-6.
2006: Ginsberg Henry N; Zhang Yuan-Li; Hernandez-Ono Antonio
Metabolic syndrome: focus on dyslipidemia.
Obesity (Silver Spring, Md.) 2006;14 Suppl 1():41S-49S.
2006: Ginsberg Henry N
REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.
The Journal of clinical endocrinology and metabolism 2006;91(2):383-92.
2005: Chen Nancy; Liu Li; Zhang Yiying; Ginsberg Henry N; Yu Yi-Hao
Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue.
Diabetes 2005;54(12):3379-86.
2005: Myerson Merle; Ngai Colleen; Jones Jeffrey; Holleran Steve; Ramakrishnan Rajasekhar; Berglund Lars; Ginsberg Henry N
Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia.
Journal of lipid research 2005;46(12):2735-44.
2005: Thomas-Geevarghese Asha; Raghavan Subhashree; Minolfo Robert; Holleran Steve; Ramakrishnan Rajasekhar; Ormsby Bernard; Karmally Wahida; Ginsberg Henry N; El-Sadr Wafaa M; Albu Jeanine; Berglund Lars
Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
The American journal of clinical nutrition 2005;82(1):146-54.
2005: Karmally Wahida; Montez Maria G; Palmas Walter; Martinez Wendy; Branstetter Anita; Ramakrishnan Rajasekhar; Holleran Steve F; Haffner Steven M; Ginsberg Henry N
Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans.
Journal of the American Dietetic Association 2005;105(6):967-70.
2005: Ginsberg Henry N; Zhang Yuan-Li; Hernandez-Ono Antonio
Regulation of plasma triglycerides in insulin resistance and diabetes.
Archives of medical research 2005;36(3):232-40.
2005: Yu Yi-Hao; Ginsberg Henry N
Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue.
Circulation research 2005;96(10):1042-52.
2005: Nagashima Kazunori; Lopez Carlos; Donovan Daniel; Ngai Colleen; Fontanez Nelson; Bensadoun André; Fruchart-Najib Jamila; Holleran Steve; Cohn Jeffrey S; Ramakrishnan Rajasekhar; Ginsberg Henry N
Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.
The Journal of clinical investigation 2005;115(5):1323-32.
2004: Liang John J; Oelkers Peter; Guo Cuiying; Chu Pi-Chun; Dixon Joseph L; Ginsberg Henry N; Sturley Stephen L
Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells.
The Journal of biological chemistry 2004;279(43):44938-44.
2004: Pan Meihui; Cederbaum Arthur I; Zhang Yuan-Li; Ginsberg Henry N; Williams Kevin Jon; Fisher Edward A
Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.
The Journal of clinical investigation 2004;113(9):1277-87.
2004: Zhang Yuan-Li; Hernandez-Ono Antonio; Ko Carol; Yasunaga Koichi; Huang Li-Shin; Ginsberg Henry N
Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.
The Journal of biological chemistry 2004;279(18):19362-74.
2004: Sherwin Robert S; Anderson Robert M; Buse John B; Chin Marshall H; Eddy David; Fradkin Judith; Ganiats Theodore G; Ginsberg Henry N; Kahn Richard; Nwankwo Robin; Rewers Marion; Schlessinger Leonard; Stern Michael; Vinicor Frank; Zinman Bernard;
Prevention or delay of type 2 diabetes.
Diabetes care 2004;27 Suppl 1():S47-54.
2004: Yu Yi-Hao; Ginsberg Henry N
The role of acyl-CoA:diacylglycerol acyltransferase (DGAT) in energy metabolism.
Annals of medicine 2004;36(4):252-61.
2003: Yamaguchi Junji; Gamble Mary V; Conlon Donna; Liang Jun-shan; Ginsberg Henry N
The conversion of apoB100 low density lipoprotein/high density lipoprotein particles to apoB100 very low density lipoproteins in response to oleic acid occurs in the endoplasmic reticulum and not in the Golgi in McA RH7777 cells.
The Journal of biological chemistry 2003;278(43):42643-51.
2003: Siri Patty W; Ginsberg Henry N
Ovariectomy leads to increased insulin resistance in human apolipoprotein B transgenic mice lacking brown adipose tissue.
Metabolism: clinical and experimental 2003;52(6):659-61.
2003: Liang Jun-Shan; Kim Tonia; Fang Shengyun; Yamaguchi Junji; Weissman Allan M; Fisher Edward A; Ginsberg Henry N
Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells.
The Journal of biological chemistry 2003;278(26):23984-8.
2003: Ginsberg Henry N
Treatment for patients with the metabolic syndrome.
The American journal of cardiology 2003;91(7A):29E-39E.
2003: Ginsberg Henry N; Stalenhoef Anton F H
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
Journal of cardiovascular risk 2003;10(2):121-8.
2002: Yu Yi-Hao; Zhang Yiying; Oelkers Peter; Sturley Stephen L; Rader Daniel J; Ginsberg Henry N
Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes.
The Journal of biological chemistry 2002;277(52):50876-84.
2002: Ginsberg Henry N
New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism.
Circulation 2002;106(16):2137-42.
2002: Fisher Edward A; Ginsberg Henry N
Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins.
The Journal of biological chemistry 2002;277(20):17377-80.
2002: Saland Jeffrey M; Ginsberg Henry; Fisher Edward A
Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.
Current opinion in pediatrics 2002;14(2):197-204.
2002: Pan Meihui; Liang Js Jun-shan; Fisher Edward A; Ginsberg Henry N
The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis.
The Journal of biological chemistry 2002;277(6):4413-21.
2002: Ginsberg Henry N
Dyslipidemia of insulin resistance syndrome explained; need for treatment to reduce risk emphasized.
The American journal of managed care 2002;Suppl():7.
2002: Ginsberg Henry N
Risk factors common to insulin resistance and atherosclerosis explain why diabetes is a cardiovascular disease.
The American journal of managed care 2002;Suppl():3, 5.
2001: Liang J S; Distler O; Cooper D A; Jamil H; Deckelbaum R J; Ginsberg H N; Sturley S L
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia.
Nature medicine 2001;7(12):1327-31.
2001: Siri P; Candela N; Zhang Y L; Ko C; Eusufzai S; Ginsberg H N; Huang L S
Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.
The Journal of biological chemistry 2001;276(49):46064-72.
2001: Ginsberg H N; Tuck C
Diabetes and dyslipidemia.
Current diabetes reports 2001;1(2):93-5.
2001: Dong Q; Ginsberg H N; Erlanger B F
Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance.
Diabetes, obesity & metabolism 2001;3(5):360-6.
2001: Ginsberg H N; Illingworth D R
Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.
The American journal of cardiology 2001;88(6A):9H-15H.
2001: Talmud P J; Berglund L; Hawe E M; Waterworth D M; Isasi C R; Deckelbaum R E; Starc T; Ginsberg H N; Humphries S E; Shea S
Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study.
Pediatrics 2001;108(3):E50.
2001: Liang J; Ginsberg H N
Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells.
The Journal of biological chemistry 2001;276(30):28606-12.
2001: Ginsberg H N
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy.
The American journal of cardiology 2001;87(10):1174-80; A4.
2001: Benhizia F; Ginsberg H N; Humphries S E; Talmud P J
Variation in the human ApoB signal peptide modulates ApoB17 translocation.
Biochemical and biophysical research communications 2001;283(1):149-57.
2001: Pariyarath R; Wang H; Aitchison J D; Ginsberg H N; Welch W J; Johnson A E; Fisher E A
Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.
The Journal of biological chemistry 2001;276(1):541-50.
2001: Ginsberg H N; Tuck C
Diabetes and dyslipidemia.
Heart failure monitor 2001;2(1):14-20.
2000: Ginsberg H N
Nonpharmacologic management of low levels of high-density lipoprotein cholesterol.
The American journal of cardiology 2000;86(12A):41L-45L.
2000: Couch S C; Isasi C R; Karmally W; Blaner W S; Starc T J; Kaluski D; Deckelbaum R J; Ginsberg H N; Shea S; Berglund L
Predictors of postprandial triacylglycerol response in children: the Columbia University Biomarkers Study.
The American journal of clinical nutrition 2000;72(5):1119-27.
2000: Ginsberg H N; Huang L S
The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis.
Journal of cardiovascular risk 2000;7(5):325-31.
2000: Liang S; Wu X; Fisher E A; Ginsberg H N
The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon.
The Journal of biological chemistry 2000;275(41):32003-10.
2000: Fard A; Tuck C H; Donis J A; Sciacca R; Di Tullio M R; Wu H D; Bryant T A; Chen N T; Torres-Tamayo M; Ramasamy R; Berglund L; Ginsberg H N; Homma S; Cannon P J
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(9):2039-44.
2000: Pan M; Liang J s; Fisher E A; Ginsberg H N
Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B.
The Journal of biological chemistry 2000;275(35):27399-405.
2000: Ginsberg H N
Insulin resistance and cardiovascular disease.
The Journal of clinical investigation 2000;106(4):453-8.
2000: Anderson J W; Davidson M H; Blonde L; Brown W V; Howard W J; Ginsberg H; Allgood L D; Weingand K W
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.
The American journal of clinical nutrition 2000;71(6):1433-8.
2000: Goldberg I J; Vanni-Reyes T; Ramakrishnan S; Holleran S; Ginsberg H N
Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Journal of cardiovascular risk 2000;7(1):41-7.
1999: Berglund L; Oliver E H; Fontanez N; Holleran S; Matthews K; Roheim P S; Ginsberg H N; Ramakrishnan R; Lefevre M
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects.
The American journal of clinical nutrition 1999;70(6):992-1000.
1999: Ginsberg H; Plutzky J; Sobel B E
A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering.
Journal of cardiovascular risk 1999;6(5):337-46.
1999: Ginsberg H N
Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.
Current cardiology reports 1999;1(3):233-7.
1998: Liang J; Wu X; Jiang H; Zhou M; Yang H; Angkeow P; Huang L S; Sturley S L; Ginsberg H
Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains.
The Journal of biological chemistry 1998;273(52):35216-21.
1998: Mitchell D M; Zhou M; Pariyarath R; Wang H; Aitchison J D; Ginsberg H N; Fisher E A
Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(25):14733-8.
1998: Jiang H; Ginsberg H N; Wu X
Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis.
Journal of lipid research 1998;39(11):2277-85.
1998: Ginsberg H N
Lipoprotein physiology.
Endocrinology and metabolism clinics of North America 1998;27(3):503-19.
1998: Zhou M; Fisher E A; Ginsberg H N
Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
The Journal of biological chemistry 1998;273(38):24649-53.
1998: Taskinen M R; Ginsberg H N
Lipid metabolism: new approaches to old problems.
Current opinion in lipidology 1998;9(3):185-7.
1998: Talmud P J; Hall S; Holleran S; Ramakrishnan R; Ginsberg H N; Humphries S E
LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics.
Journal of lipid research 1998;39(6):1189-96.
1998: Berglund L; Witztum J L; Galeano N F; Khouw A S; Ginsberg H N; Ramakrishnan R
Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.
Journal of lipid research 1998;39(4):913-24.
1998: Ginsberg H N; Kris-Etherton P; Dennis B; Elmer P J; Ershow A; Lefevre M; Pearson T; Roheim P; Ramakrishnan R; Reed R; Stewart K; Stewart P; Phillips K; Anderson N
Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(3):441-9.
1998: Ginsberg H N
Effects of statins on triglyceride metabolism.
The American journal of cardiology 1998;81(4A):32B-35B.
1997: Wu X; Shang A; Jiang H; Ginsberg H N
Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):3347-55.
1997: Lefevre M; Ginsberg H N; Kris-Etherton P M; Elmer P J; Stewart P W; Ershow A; Pearson T A; Roheim P S; Ramakrishnan R; Derr J; Gordon D J; Reed R
ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. The DELTA Research Group. Dietary Effects on Lipoproteins and Thrombogenic Activity.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2914-23.
1997: Harris W S; Ginsberg H N; Arunakul N; Shachter N S; Windsor S L; Adams M; Berglund L; Osmundsen K
Safety and efficacy of Omacor in severe hypertriglyceridemia.
Journal of cardiovascular risk 1997;4(5-6):385-91.
1997: Fisher E A; Zhou M; Mitchell D M; Wu X; Omura S; Wang H; Goldberg A L; Ginsberg H N
The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.
The Journal of biological chemistry 1997;272(33):20427-34.
1997: Ginsberg H N; Taskinen M R
New insights into the regulation of lipoprotein metabolism: studies in procaryocytes, eukaryocytes, rodents, pigs, and people.
Current opinion in lipidology 1997;8(3):127-30.
1997: Ginsberg H N
Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer.
Annals of internal medicine 1997;126(11):912-4.
1997: Ginsberg H N
Role of lipid synthesis, chaperone proteins and proteasomes in the assembly and secretion of apoprotein B-containing lipoproteins from cultured liver cells.
Clinical and experimental pharmacology & physiology 1997;24(5):A29-32.
1997: Wu X; Sakata N; Lele K M; Zhou M; Jiang H; Ginsberg H N
A two-site model for ApoB degradation in HepG2 cells.
The Journal of biological chemistry 1997;272(17):11575-80.
1997: Naganawa S; Ginsberg H N; Glickman R M; Ginsburg G S
Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.
The Journal of clinical investigation 1997;99(8):1958-65.
1996: Zhou M; Wu X; Ginsberg H N
Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cells.
The Journal of biological chemistry 1996;271(40):24769-75.
1996: Ginsberg H N
Cyclosporine, plasma lipids, and organ transplantation.
Hepatology (Baltimore, Md.) 1996;24(3):735-6.
1996: Shachter N S; Ebara T; Ramakrishnan R; Steiner G; Breslow J L; Ginsberg H N; Smith J D
Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
The Journal of clinical investigation 1996;98(3):846-55.
1996: Ginsberg H N
Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels.
Diabetes 1996;45 Suppl 3():S27-30.
1996: Wu X; Shang A; Jiang H; Ginsberg H N
Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool.
Journal of lipid research 1996;37(6):1198-206.
1996: Wu X; Zhou M; Huang L S; Wetterau J; Ginsberg H N
Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins.
The Journal of biological chemistry 1996;271(17):10277-81.
1995: Ginsberg H N; Karmally W
Zinc supplementation during pregnancy.
JAMA : the journal of the American Medical Association 1995;274(24):1909-10.
1995: Ginsberg H N; Jones J; Blaner W S; Thomas A; Karmally W; Fields L; Blood D; Begg M D
Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(11):1829-38.
1995: Ginsberg H N
Synthesis and secretion of apolipoprotein B from cultured liver cells.
Current opinion in lipidology 1995;6(5):275-80.
1995: Zhou M; Wu X; Huang L S; Ginsberg H N
Apoprotein B100, an inefficiently translocated secretory protein, is bound to the cytosolic chaperone, heat shock protein 70.
The Journal of biological chemistry 1995;270(42):25220-4.
1995: Ginsberg H N
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
Clinical cardiology 1995;18(6):307-15.
1995: Ginsberg H N
Low HDL cholesterol: what are the prospects of increasing it?
Annals of medicine 1995;27(3):283-4.
1995: Mayeux R; Ottman R; Maestre G; Ngai C; Tang M X; Ginsberg H; Chun M; Tycko B; Shelanski M
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.
Neurology 1995;45(3 Pt 1):555-7.
1995: Ginsberg H N; Karmally W; Siddiqui M; Holleran S; Tall A R; Blaner W S; Ramakrishnan R
Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(2):169-78.
1995: Ginsberg H N
New directions in dietary studies and heart disease: the National Heart, Lung and Blood Institute sponsored Multicenter Study of Diet Effects on Lipoproteins and Thrombogenic Activity.
Advances in experimental medicine and biology 1995;369():241-7.
1994: Rumsey S C; Stucchi A F; Nicolosi R J; Ginsberg H N; Ramakrishnan R; Deckelbaum R J
Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys.
Journal of lipid research 1994;35(9):1592-8.
1994: Wu X; Sakata N; Dixon J; Ginsberg H N
Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms.
Journal of lipid research 1994;35(7):1200-10.
1994: Ginsberg H N; Karmally W; Barr S L; Johnson C; Holleran S; Ramakrishnan R
Effects of increasing dietary polyunsaturated fatty acids within the guidelines of the AHA step 1 diet on plasma lipid and lipoprotein levels in normal males.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(6):892-901.
1994: Shachter N S; Hayek T; Leff T; Smith J D; Rosenberg D W; Walsh A; Ramakrishnan R; Goldberg I J; Ginsberg H N; Breslow J L
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.
The Journal of clinical investigation 1994;93(4):1683-90.
1994: Wu X; Sakata N; Lui E; Ginsberg H N
Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
The Journal of biological chemistry 1994;269(16):12375-82.
1994: Ginsberg H N; Karmally W; Siddiqui M; Holleran S; Tall A R; Rumsey S C; Deckelbaum R J; Blaner W S; Ramakrishnan R
A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(4):576-86.
1994: Sprecher D L; Abrams J; Allen J W; Keane W F; Chrysant S G; Ginsberg H; Fischer J J; Johnson B F; Theroux P; Jokubaitis L
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
Annals of internal medicine 1994;120(7):537-43.
1994: Ginsberg H N
Lipoprotein metabolism and its relationship to atherosclerosis.
The Medical clinics of North America 1994;78(1):1-20.
1993: Mayeux R; Stern Y; Ottman R; Tatemichi T K; Tang M X; Maestre G; Ngai C; Tycko B; Ginsberg H
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease.
Annals of neurology 1993;34(5):752-4.
1993: Sakata N; Wu X; Dixon J L; Ginsberg H N
Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
The Journal of biological chemistry 1993;268(31):22967-70.
1993: Ginsberg H N; Tall A R; Deckelbaum R J
Treatment of and screening for hyperlipidemia.
The New England journal of medicine 1993;329(15):1126-7; author reply 1127-8.
1993: Ginsberg H N
Syndrome X: what's old, what's new, what's etiologic?
The Journal of clinical investigation 1993;92(1):3.
1993: Ginsberg H N; Ngai C; Wang X J; Ramakrishnan R
Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(6):842-51.
1993: Horowitz B S; Goldberg I J; Merab J; Vanni T M; Ramakrishnan R; Ginsberg H N
Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.
The Journal of clinical investigation 1993;91(4):1743-52.
1993: Dixon J L; Ginsberg H N
Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells.
Journal of lipid research 1993;34(2):167-79.
1992: Moulin P; Appel G B; Ginsberg H N; Tall A R
Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia.
Journal of lipid research 1992;33(12):1817-22.
1992: Dixon J L; Ginsberg H N
Hepatic synthesis of lipoproteins and apolipoproteins.
Seminars in liver disease 1992;12(4):364-72.
1992: Aalto-Setälä K; Fisher E A; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg H N; Breslow J L
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
The Journal of clinical investigation 1992;90(5):1889-900.
1992: Furukawa S; Sakata N; Ginsberg H N; Dixon J L
Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
The Journal of biological chemistry 1992;267(31):22630-8.
1992: Arad Y; Ramakrishnan R; Ginsberg H N
Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins.
Metabolism: clinical and experimental 1992;41(5):487-93.
1992: Barr S L; Ramakrishnan R; Johnson C; Holleran S; Dell R B; Ginsberg H N
Reducing total dietary fat without reducing saturated fatty acids does not significantly lower total plasma cholesterol concentrations in normal males.
The American journal of clinical nutrition 1992;55(3):675-81.
1991: Swayne L C; Caruana V; Ginsberg H N; Mody M A
Potential false-positive red blood cell gastrointestinal bleeding study secondary to osseous metastasis.
Clinical nuclear medicine 1991;16(10):770-1.
1991: Ginsberg H N
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Diabetes care 1991;14(9):839-55.
1991: Swayne L C; Ginsberg H N; Parr G V
Unusual collateral venous blood flow following surgical repair of a thoracic aortic dissection.
Clinical nuclear medicine 1991;16(4):283-4.
1991: Dixon J L; Furukawa S; Ginsberg H N
Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.
The Journal of biological chemistry 1991;266(8):5080-6.
1990: Ramakrishnan R; Arad Y; Wong S; Ginsberg H N
Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B.
Journal of lipid research 1990;31(6):1031-42.
1990: Ginsberg H N
Lipoprotein physiology and its relationship to atherogenesis.
Endocrinology and metabolism clinics of North America 1990;19(2):211-28.
1990: Usiskin K S; Butterworth S; Clore J N; Arad Y; Ginsberg H N; Blackard W G; Nestler J E
Lack of effect of dehydroepiandrosterone in obese men.
International journal of obesity 1990;14(5):457-63.
1990: Arad Y; Ramakrishnan R; Ginsberg H N
Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.
Journal of lipid research 1990;31(4):567-82.
1990: Ginsberg H N; Goldsmith S J; Vallabhajosula S
Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients.
Arteriosclerosis (Dallas, Tex.) 1990;10(2):256-62.
1990: Rosen J M; Butler S P; Meinken G E; Wang T S; Ramakrishnan R; Srivastava S C; Alderson P O; Ginsberg H N
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(3):343-50.
1990: Ginsberg H N; Barr S L; Gilbert A; Karmally W; Deckelbaum R; Kaplan K; Ramakrishnan R; Holleran S; Dell R B
Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat.
The New England journal of medicine 1990;322(9):574-9.
1989: Grundy S M; Brown W V; Dietschy J M; Ginsberg H; Goodnight S; Howard B; La Rosa J C; McGill H C
AHA Conference Report on Cholesterol. Basis for dietary treatment.
Circulation 1989;80(3):729-34.
1989: Swayne L C; Ginsberg H N
Diagnosis of acute cholecystitis by cholescintigraphy: significance of pericholecystic hepatic uptake.
AJR. American journal of roentgenology 1989;152(6):1211-3.
1989: Tint G S; Ginsberg H; Salen G; Le N A; Shefer S
Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
Journal of lipid research 1989;30(5):633-40.
1989: Swayne L C; Ginsberg H N
Pericholecystic hepatic activity in a postcholecystectomy patient.
Clinical nuclear medicine 1989;14(5):382-3.
1989: Kindman L A; Gilbert H S; Almenoff J S; Ginsberg H; Fagerstrom R; Teirstein A S
High-density lipoprotein cholesterol is reduced in patients with sarcoidosis.
The American journal of medicine 1989;86(4):376-8.
1989: Arad Y; Badimon J J; Badimon L; Hembree W C; Ginsberg H N
Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit.
Arteriosclerosis (Dallas, Tex.) 1989;9(2):159-66.
1989: Vallabhajosula S; Gilbert H S; Goldsmith S J; Paidi M; Hanna M M; Ginsberg H N
Low-density lipoprotein (LDL) distribution shown by 99mtechnetium-LDL imaging in patients with myeloproliferative diseases.
Annals of internal medicine 1989;110(3):208-13.
1989: Goldberg A C; Schonfeld G; Feldman E B; Ginsberg H N; Hunninghake D B; Insull W; Knopp R H; Kwiterovich P O; Mellies M J; Pickering J
Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.
Clinical therapeutics 1989;11(1):69-83.
1988: Vallabhajosula S; Paidi M; Badimon J J; Le N A; Goldsmith S J; Fuster V; Ginsberg H N
Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(7):1237-45.
1988: Le N A; Ginsberg H N
Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol.
Metabolism: clinical and experimental 1988;37(7):614-7.
1988: Le N A; Gibson J C; Ginsberg H N
Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
Journal of lipid research 1988;29(5):669-77.
1988: Ginsberg H N; Swayne L C; Peron D L; Magidson J G; Newcomb A W
Bilateral temporal bone involvement with eosinophilic granuloma.
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 1988;12(2):107-10.
1988: Le N A; Gibson J C; Rubinstein A; Grabowski G A; Ginsberg H N
Abnormalities in lipoprotein metabolism in Gaucher type 1 disease.
Metabolism: clinical and experimental 1988;37(3):240-5.
1988: Goldberg I J; Le N A; Ginsberg H N; Krauss R M; Lindgren F T
Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
The Journal of clinical investigation 1988;81(2):561-8.
1987: Ginsberg H N; Le N A; Short M P; Ramakrishnan R; Desnick R J
Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.
The Journal of clinical investigation 1987;80(6):1692-7.
1987: Ginsberg H N
Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives.
The American journal of medicine 1987;83(5B):66-70.
1987: Ginsberg H N; Swayne L C
Three-phase bone scanning in chronic myelogenous leukemia.
Clinical nuclear medicine 1987;12(10):823-4.
1987: Gibson J C; Goldberg R B; Rubinstein A; Ginsberg H N; Brown W V; Baker S; Joffe B I; Seftel H C
Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.
Arteriosclerosis (Dallas, Tex.) 1987;7(4):401-7.
1987: Ginsberg H N
Very low density lipoprotein metabolism in diabetes mellitus.
Diabetes/metabolism reviews 1987;3(2):571-89.
1987: Swayne L C; Ginsberg H N; Ginsburg A
Pneumoretroperitoneum secondary to hydrogen peroxide wound irrigations.
AJR. American journal of roentgenology 1987;148(1):149-50.
1986: Goldberg I J; Kandel J J; Blum C B; Ginsberg H N
Association of plasma lipoproteins with postheparin lipase activities.
The Journal of clinical investigation 1986;78(6):1523-8.
1986: Rubinstein A; Gibson J C; Ginsberg H N; Brown W V
In vitro metabolism of apolipoprotein E.
Biochimica et biophysica acta 1986;879(3):355-61.
1986: Ginsberg H N; Le N A; Goldberg I J; Gibson J C; Rubinstein A; Wang-Iverson P; Norum R; Brown W V
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
The Journal of clinical investigation 1986;78(5):1287-95.
1986: Ginsberg H N; Le N A; Gilbert H S
Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia.
Metabolism: clinical and experimental 1986;35(9):878-82.
1986: Budd D; Ginsberg H
Hypocholesterolemia and acute myelogenous leukemia. Association between disease activity and plasma low-density lipoprotein cholesterol concentrations.
Cancer 1986;58(6):1361-5.
1986: Ginsberg H N
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal.
The American journal of psychiatry 1986;143(7):938.
1986: Ginsberg H; Rubenstein A; Brown W V
Medical complications of isotretinoin.
Clinics in dermatology 1986;4(1):183-9.
1986: Gibson J C; Rubinstein A; Ginsberg H N; Brown W V
Isolation of apolipoprotein E-containing lipoproteins by immunoaffinity chromatography.
Methods in enzymology 1986;129():186-98.
1986: Le N A; Bukberg P R; Ginsberg H N; Gibson J C; Brown W V
Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography.
Methods in enzymology 1986;129():457-69.
1986: Le N A; Ramakrishnan R; Dell R B; Ginsberg H N; Brown W V
Kinetic analysis using specific radioactivity data.
Methods in enzymology 1986;129():384-95.
1986: Norum R A; Forte T M; Alaupovic P; Ginsberg H N
Clinical syndrome and lipid metabolism in hereditary deficiency of apolipoproteins A-I and C-III, variant 1.
Advances in experimental medicine and biology 1986;201():137-49.
1985: Bershad S; Rubinstein A; Paterniti J R; Le N A; Poliak S C; Heller B; Ginsberg H N; Fleischmajer R; Brown W V
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
The New England journal of medicine 1985;313(16):981-5.
1985: Bukberg P R; Le N A; Ginsberg H N; Gibson J C; Rubinstein A; Brown W V
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
Journal of lipid research 1985;26(9):1047-57.
1985: Gibson J C; Rubinstein A; Brown W V; Ginsberg H N; Greten H; Norum R; Kayden H
Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
Arteriosclerosis (Dallas, Tex.) 1985;5(4):371-80.
1985: Gibson J C; Rubinstein A; Ngai N; Ginsberg H N; Le N A; Gordon R E; Goldberg I J; Brown W V
Immunoaffinity isolation of apolipoprotein E-containing lipoproteins.
Biochimica et biophysica acta 1985;835(1):113-23.
1985: Rubinstein A; Gibson J C; Paterniti J R; Kakis G; Little A; Ginsberg H N; Brown W V
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
The Journal of clinical investigation 1985;75(2):710-21.
1985: Ginsberg H N; Le N A; Gibson J C
Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
The Journal of clinical investigation 1985;75(2):614-23.
1985: Wang-Iverson P; Ginsberg H N; Peteanu L A; Le N A; Brown W V
Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor.
Biochemical and biophysical research communications 1985;126(1):578-86.
1984: Le N A; Ginsberg H N; Brown W V
Protocol for efficient plasma sampling for low density lipoprotein turnover studies.
Journal of lipid research 1984;25(12):1387-91.
1984: Franklin B; Ginsberg H; Haque W U; Yeh H C; Horlick M N; Paterniti J R; Gibson J; Le A N; Ginsberg-Fellner F
Very low-density lipoprotein metabolism in an unusual case of lipoatrophic diabetes.
Metabolism: clinical and experimental 1984;33(9):814-9.
1984: Brown W V; Ginsberg H; Karmally W
Diet and the decrease of coronary heart disease.
The American journal of cardiology 1984;54(5):27C-29C.
1984: Ginsberg H; Grabowski G A; Gibson J C; Fagerstrom R; Goldblatt J; Gilbert H S; Desnick R J
Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease.
Clinical genetics 1984;26(2):109-16.
1984: Gilbert H S; Stump D D; Ginsberg H; Roth E F
The effect of chronic hypocholesterolemia in myeloproliferative disease on the distribution of plasma and erythrocyte tocopherol.
The American journal of clinical nutrition 1984;40(1):95-100.
1984: Brown W V; Goldberg I J; Ginsberg H N
Treatment of common lipoprotein disorders.
Progress in cardiovascular diseases 1984;27(1):1-20.
1984: Gilbert H S; Roth E F; Ginsberg H
Increased erythrocyte susceptibility to lipid peroxidation in myeloproliferative disorders.
The Journal of laboratory and clinical medicine 1984;103(1):6-13.
1984: Ginsberg H; Gilbert H S
Hypocholesterolemia in myeloproliferative diseases with myelofibrosis.
Progress in clinical and biological research 1984;154():345-57.
1983: Bukberg P R; Le N A; Ginsberg H N; Gibson J C; Goldman L C; Brown W V
Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography.
Journal of lipid research 1983;24(9):1251-60.
1983: Goldberg I J; Paterniti J R; Franklin B H; Ginsberg H N; Ginsberg-Fellner F; Brown W V
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
The American journal of the medical sciences 1983;286(2):28-31.
1983: Paterniti J R; Brown W V; Ginsberg H N; Artzt K
Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse.
Science (New York, N.Y.) 1983;221(4606):167-9.
1983: Ginsberg H; Goldberg I J; Wang-Iverson P; Gitler E; Le N A; Gilbert H S; Brown W V
Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases.
Arteriosclerosis (Dallas, Tex.) 1983;3(3):233-41.
1983: Gilbert H S; Ginsberg H
Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemia.
Cancer 1983;51(8):1428-33.
1983: Goldberg I J; Le N A; Ginsberg H N; Paterniti J R; Brown W V
Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B.
The American journal of physiology 1983;244(2):E196-201.
1982: Goldberg I J; Le N A; Paterniti J R; Ginsberg H N; Lindgren F T; Brown W V
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.
The Journal of clinical investigation 1982;70(6):1184-92.
1982: Ginsberg H N; Jacobs A; Le N A; Sandler J
Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.
The Journal of clinical investigation 1982;70(6):1225-33.
1982: Ginsberg H; Grundy S M
Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: effect of dietary restriction.
Diabetologia 1982;23(5):421-5.
1982: Abrams J J; Ginsberg H; Grundy S M
Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus.
Diabetes 1982;31(10):903-10.
1982: Ginsberg H; Davidson N; Le N A; Gibson J; Ahrens E H; Brown W V
Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
Biochimica et biophysica acta 1982;712(2):250-7.
1982: Brown W V; Bloomgarden Z; Ginsberg H
Lipoproteins as risk factors for vascular disease in diabetes.
The Mount Sinai journal of medicine, New York 1982;49(3):176-86.
1982: Ginsberg H; Gilbert H S; Gibson J C; Le N A; Brown W V
Increased low-density-lipoprotein catabolism in myeloproliferative disorders.
Annals of internal medicine 1982;96(3):311-6.
1981: Ginsberg H; Le N A; Mays C; Gibson J; Brown W V
Lipoprotein metabolism in nonresponders to increased dietary cholesterol.
Arteriosclerosis (Dallas, Tex.) 1981;1(6):463-70.
1981: Gilbert H S; Ginsberg H; Fagerstrom R; Brown W V
Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.
The American journal of medicine 1981;71(4):595-602.
1981: Ginsberg H; Rayfield E J
Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity.
Diabetes 1981;30(9):739-45.
1981: Ginsberg H N; Le N A; Melish J; Steinberg D; Brown W V
Effect of a high carbohydrate diet on apoprotein-B catabolism in man.
Metabolism: clinical and experimental 1981;30(4):347-53.
1981: Abrams J J; Grundy S M; Ginsberg H
Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man.
Journal of lipid research 1981;22(2):307-22.
1980: Melish J; Le N A; Ginsberg H; Steinberg D; Brown W V
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.
The American journal of physiology 1980;239(5):E354-62.
1978: Yeast J D; Porreco R P; Ginsberg H N
The use of continuous insulin infusion for the peripartum management of pregnant diabetic women.
American journal of obstetrics and gynecology 1978;131(8):861-4.
1978: Le N A; Melish J S; Roach B C; Ginsberg H N; Brown W V
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins.
Journal of lipid research 1978;19(5):578-84.
1977: Ginsberg H N
Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy.
Metabolism: clinical and experimental 1977;26(10):1135-46.
1977: Ginsberg H N
Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus.
Diabetes 1977;26(4):278-83.
1976: Ginsberg H; Olefsky J M; Kimmerling G; Crapo P; Reaven G M
Induction of hypertriglyceridemia by a low-fat diet.
The Journal of clinical endocrinology and metabolism 1976;42(4):729-35.
1975: Peterson V E; Crapo P A; Weininger J; Ginsberg H; Olefsky J
Quantification of plasma cholesterol and triglyceride levels in hypercholesterolemic subjects receiving ascorbic acid supplements.
The American journal of clinical nutrition 1975;28(6):584-7.
1975: Olefsky J; Crapo P A; Ginsberg H; Reaven G M
Metabolic effects of increased caloric intake in man.
Metabolism: clinical and experimental 1975;24(4):495-503.
1975: Ginsberg H; Olefsky J M; Reaven G M
Evaluation of insulin resistance in patients with primary hyperparathyroidism.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1975;148(3):942-5.
1975: Ginsberg H; Kimmerling G; Olefsky J M; Reaven G M
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia.
The Journal of clinical investigation 1975;55(3):454-61.
1974: Ginsberg H; Olefsky J; Farquhar J W; Reaven G M
Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons.
Annals of internal medicine 1974;80(2):143-9.

Sign-in to see more